Premium
High prevalence of GB virus C/hepatitis G virus RNA in patients infected with human immunodeficiency virus
Author(s) -
Rey D.,
Fraize S.,
Vidinic J.,
Meyer P.,
Fritsch S.,
Labouret N.,
Schmitt C.,
Lang J.M.,
StollKeller F.
Publication year - 1999
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/(sici)1096-9071(199901)57:1<75::aid-jmv11>3.0.co;2-b
Subject(s) - gb virus c , virology , medicine , hepatitis d virus , virus , hbsag , hepatitis c virus , flaviviridae , viral disease , hepatitis b virus , hepatitis d
Prevalence of GBV‐C/HGV was determined in a cohort of HIV‐infected patients, via a reverse transcription–polymerase chain reaction detection of RNA in serum, amplifying the NS5 region of GBV‐C/HGV genome. GBV‐C/HGV RNA was detected in 143 (37.7%) of 379 patients, with similar results in the different HIV risk groups: 25/56 (44.6%) in intravenous drug users, 66/161 (41%) in homo‐ and bisexual men, 35/108 (32.4%) in heterosexual patients, 6/20 (30%) in transfusion recipients ( P = 0.41). There was no difference according to the presence or absence of hepatitis C virus infection. In univariate analysis, GBV‐C/HGV genome prevalence was lower in patients over 50 years old (18.2%), compared to other age groups (20–29 years: 34.2%; 30–39 years: 44.3%; 40–49 years: 36.7%, P = 0.03), as well as in patients with normal CD4 cell count (29.2% vs. 45.4% between 200–500/mm 3 , and 35.3% below 200 CD4/mm 3 , P = 0.012) and individuals with a chronic hepatitis B. However, in the multivariate analysis, the only prognostic factor of GBV‐C/HGV RNA positivity was the presence of a chronic hepatitis B, compared to the absence of any HBV marker, or a previous exposition to HBV (presence of anti‐HBc and/or anti‐HBs, absence of HBsAg), or the presence of anti‐HBs alone. J. Med. Virol. 57:75–79, 1999. © 1999 Wiley‐Liss, Inc.